X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
pcecv (24) 24
immunology (22) 22
rabies (21) 21
rabies - prevention & control (21) 21
rabies vaccines - immunology (20) 20
animals (17) 17
rabies vaccines - administration & dosage (17) 17
immunogenicity (15) 15
index medicus (15) 15
male (15) 15
pvrv (15) 15
adult (13) 13
biotechnology & applied microbiology (13) 13
chick embryo (13) 13
rabies virus - immunology (13) 13
female (12) 12
adolescent (11) 11
antibodies, viral - blood (10) 10
rabies - immunology (10) 10
rabies vaccines - adverse effects (10) 10
vaccination (10) 10
immunization (9) 9
injections, intradermal (9) 9
middle aged (9) 9
prophylaxis (9) 9
vaccines (9) 9
medicine, research & experimental (8) 8
post-exposure prophylaxis (8) 8
safety (8) 8
schedule (8) 8
antibodies, neutralizing - blood (7) 7
child (7) 7
immunization schedule (7) 7
neutralization tests (7) 7
post-exposure prophylaxis - methods (7) 7
cell (6) 6
child, preschool (6) 6
children (6) 6
proteins (6) 6
rabies vaccine (6) 6
rabies vaccines - isolation & purification (6) 6
young adult (6) 6
antibodies, viral - biosynthesis (5) 5
antibodies, viral - immunology (5) 5
binding (5) 5
biology (5) 5
bioscience (5) 5
calcium (5) 5
cancer (5) 5
cercopithecus aethiops (5) 5
cycle (5) 5
injections, intramuscular (5) 5
landes (5) 5
organogenesis (5) 5
postexposure prophylaxis (5) 5
pre-exposure prophylaxis (5) 5
vaccination - methods (5) 5
vaccine (5) 5
vero cells (5) 5
cell culture (4) 4
drug-related side effects and adverse reactions - epidemiology (4) 4
embryo cell vaccine (4) 4
hdcv (4) 4
intradermal (4) 4
lyssavirus (4) 4
purified vero cell rabies vaccine (4) 4
rabies vaccines (4) 4
rabies vaccines - economics (4) 4
regimen (4) 4
aged (3) 3
antibodies (3) 3
china (3) 3
cost (3) 3
cost-benefit analysis (3) 3
embryonic development (3) 3
exposure (3) 3
immunization, secondary (3) 3
india (3) 3
infant (3) 3
infection (3) 3
licensed vaccines (3) 3
pep, post-exposure prophylaxis (3) 3
purified chick embryo cell vaccine (3) 3
rabies virus - isolation & purification (3) 3
rabies virus neutralizing antibody (3) 3
research paper (3) 3
research papers (3) 3
rffit, rapid fluorescent focus inhibition test (3) 3
veterinary sciences (3) 3
viruses (3) 3
zagreb regimen (3) 3
adults (2) 2
ae, adverse event (2) 2
age (2) 2
aged, 80 and over (2) 2
allergy and immunology (2) 2
analysis (2) 2
animal bites (2) 2
antibodies, neutralizing - immunology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Vaccines and Immunotherapeutics, ISSN 2164-5515, 10/2014, Volume 10, Issue 10, pp. 2799 - 2804
Journal Article
Clinical Laboratory, ISSN 1433-6510, 2019, Volume 65, Issue 1-2, pp. 77 - 81
Background: Rabies is a fatal zoonotic infectious disease, which can be prevented by prompt post-exposure prophylaxis that could be expensive in countries with... 
2-1-1 regimen | Essen protocol | Zagreb protocol | Rabies post-exposure prophylaxis | IMMUNOGENICITY | SAFETY | POSTEXPOSURE PROPHYLAXIS | VACCINE PCECV | SCHEDULE | MEDICAL LABORATORY TECHNOLOGY | rabies post-exposure prophylaxis | PVRV
Journal Article
Medicine (United States), ISSN 0025-7974, 2016, Volume 95, Issue 47, p. e5049
To evaluate the safeties of 4 types of rabies vaccines for patients with WHO category II animal exposure, especially in different age groups. A total of 4000... 
Rabies vaccines | Age | Safety | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | IMMUNOGENICITY | PCECV | safety | CELL | age | rabies vaccines | Rabies - prevention & control | World Health Organization | Age Factors | Humans | Middle Aged | Child, Preschool | Infant | Male | Animals | Rabies Vaccines - adverse effects | Adolescent | Patient Safety | Adult | Female | Child | Prevention | Usage | Safety and security measures | Rabies | Children | Health aspects
Journal Article
Archives of Iranian Medicine, ISSN 1029-2977, 07/2016, Volume 19, Issue 7, pp. 502 - 507
Objective: Human rabies is preventable by prompt application of post-exposure prophylaxis (PEP). The aim of this study was to compare the adverse reactions of... 
Clinical trial | PCECV | Vaccines | Rabies | PVRV | MEDICINE, GENERAL & INTERNAL | IRAN | vaccines | POSTEXPOSURE PROPHYLAXIS | rabies | REGIMEN | PREEXPOSURE VACCINATION | SCHEDULE
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 08/2017, Volume 35, Issue 34, pp. 4315 - 4320
In the USA, rabies vaccines (RVs) are licensed for intramuscular (IM) use only, although RVs are licensed for use by the intradermal (ID) route in many other... 
Intradermal vaccination | Viral inmune responses | Rabies vaccine | Rabies | Rabies virus neutralizing antibodies | MEDICINE, RESEARCH & EXPERIMENTAL | PCECV | REGIMEN | IMMUNOLOGY | PVRV | PROPHYLAXIS | IMMUNOGENICITY | COST | ANTIBODY-RESPONSE | Immunogenicity, Vaccine | Rabies virus - isolation & purification | Rabies - prevention & control | Pre-Exposure Prophylaxis - methods | Rabies Vaccines - administration & dosage | Humans | Middle Aged | Vaccination | Male | Immunization, Secondary | Drug-Related Side Effects and Adverse Reactions | Post-Exposure Prophylaxis | Adult | Female | Cell Culture Techniques | Injections, Intradermal | Rabies virus - immunology | Injections, Intramuscular | Chick Embryo | Vaccines, Inactivated - adverse effects | Rabies Vaccines - immunology | Vaccines, Inactivated - immunology | Animals | Vaccines, Inactivated - administration & dosage | Rabies Vaccines - adverse effects | Antibodies, Viral - immunology | Rabies virus - growth & development | Antibodies, Neutralizing - blood | Prevention | Embryonic development | Embryo | Adults | Vaccines | Cell culture | Immunization | Immunoglobulins | Statistical analysis | Prophylaxis | Antibodies | Fluorescence | Licenses | Viruses | Product recalls | Travel | Side effects | Immunogenicity | Medical laboratories | Risk assessment | Neutralizing | Vials | Erythema
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2735, 03/2011, Volume 5, Issue 3, p. e982
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 06/2018, Volume 12, Issue 6, p. e0006340
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 07/2016, Volume 12, Issue 7, pp. 1802 - 1804
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 07/2013, Volume 9, Issue 7, pp. 1454 - 1459
Journal Article
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 08/2012, Volume 8, Issue 8, pp. 1077 - 1081
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 10/2014, Volume 10, Issue 10, pp. 2805 - 2812
The Zagreb regimen has been used for 20 years in various countries. In China, until 2010, the Zagreb schedule was only approved for purified chick embryo cell... 
chick-embryo cells | PCECV | rabies vaccine | safety | neutralizing antibody | Zagreb regimen | immunogenicity | Immunogenicity | Chick-embryo cells | Rabies vaccine | Safety | Neutralizing antibody | PDEV | human diploid cell rabies vaccine | FDA | geometric mean concentration | pre-exposure prophylaxis | ANTIBODY | IMMUNOLOGY | cell culture or embryonated egg-based rabies vaccines | HDCV | RVNA | PPS | COST | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | serious adverse event | CCEEV | purified chick embryo cell rabies vaccine | RFFIT | SCHEDULE | GMC | post-exposure prophylaxis | rabies virus neutralizing antibody | Food and Drug Administration | WHO | purified Vero cell rabies vaccine | World Health Organization | POSTEXPOSURE PROPHYLAXIS | adverse event | PrEP | PVRV | purified duck embryo cell vaccine | rapid fluorescent focus inhibition test | per protocol set | SAE | confidence interval | PEP | Rabies - prevention & control | Rabies virus - immunology | Rabies Vaccines - administration & dosage | Humans | Middle Aged | Vaccination | Cercopithecus aethiops | Male | Antibodies, Viral - blood | Chick Embryo | Young Adult | Antibodies, Neutralizing - immunology | Rabies Vaccines - immunology | Animals | China | Cost-Benefit Analysis | Adolescent | Post-Exposure Prophylaxis | Adult | Antibodies, Viral - immunology | Female | Immunization Schedule | Vero Cells | Antibodies, Neutralizing - blood
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 12/2014, Volume 10, Issue 12, pp. 3622 - 3626
Journal Article
Human Vaccines, ISSN 1554-8600, 07/2011, Volume 7, Issue 7, pp. 792 - 794
Journal Article